Cargando…
Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study
Topical imiquimod could be an alternative, noninvasive, treatment modality for high-grade cervical intraepithelial neoplasia (CIN). However, evidence is limited, and there are no studies that compared treatment effectiveness and side effects of topical imiquimod cream to standard large loop excision...
Autores principales: | Hendriks, Natasja, Koeneman, Margot M., van de Sande, Anna J.M., Penders, Charlotte G.J., Piek, Jurgen M.J., Kooreman, Loes F.S., van Kuijk, Sander M.J., Hoosemans, Linde, Sep, Simone J.S., de Vos Van Steenwijk, Peggy J., van Beekhuizen, Heleen J., Slangen, Brigitte F.M., Nijman, Hans W., Kruitwagen, Roy F.P.M., Kruse, Arnold-Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906243/ https://www.ncbi.nlm.nih.gov/pubmed/35180719 http://dx.doi.org/10.1097/CJI.0000000000000414 |
Ejemplares similares
-
Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial
por: Koeneman, M. M., et al.
Publicado: (2017) -
TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial
por: Koeneman, M. M., et al.
Publicado: (2016) -
TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial
por: van de Sande, A. J. M., et al.
Publicado: (2018) -
Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia – A case series
por: Wouters, Tirza, et al.
Publicado: (2019) -
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions
por: Abdulrahman, Ziena, et al.
Publicado: (2022)